- FDA Approves Medtronic Pain Pump App
- FDA Panel OKs Stronger Opioid Despite Concerns
- FDA Takes New Steps To Address Epidemic Of Youth E-Cigarette Use, Including A Historic Action Against More Than 1,300 Retailers And 5 Major Manufacturers For Their Roles Perpetuating Youth Access
- FDA Approves New Dosage Strength of Buprenorphine and Naloxone Sublingual Film as Maintenance Treatment for Opioid Dependence
- Opioids and the internet: Convergence of technology and policy to address the illicit online sales of opioids.
- FDA Summit Aims to Crack the Code On Online Opioid Sales
- FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
- FDA Takes Steps to Encourage Development of Treatments for Opioid Use Disorder
- FDA to Review Long-Acting Treatment for Opioid Use Disorder